Log in to search using one of your social media accounts:

 

Correspondence HPV control and resistance in the Middle East and north Africa

We thank Murat G ültekin and Baki Akgül,1 and we agree wholeheartedly with the fact that Islamic countries, and countries with more conservative sexual views based on religion in general, should implement educational projects in government-organised programmes. As we mentioned in our original Correspondence,2 the organisation of intervention policies based on awareness campaigns can be a very effective first step in the control of cervical cancer caused by HPV. However, a point that we would like to stress once more is that acceptance and implementation of these programmes, and in effect also vaccines, can b e faced with difficulties because of stigmatisation that is based on religious and traditional values.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research

Related Links:

The incidence of mouth and throat cancers caused by the human papillomavirus in men has now surpassed the incidence of HPV-related cervical cancers in women.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Head and Neck Cancer Human Papillomavirus (HPV) Sexually Transmitted Diseases Throat Smoking and Tobacco Men and Boys Vaccination and Immunization Infections Source Type: news
CONCLUSIONS: Cervical screening and HPV vaccination uptake were very low among HIV-infected women in care in Uganda. Improved knowledge of cervical screening schedules and sites, and addressing fears and risk perception may increase uptake of cervical screening in this vulnerable population. PMID: 29035163 [PubMed - in process]
Source: Global Health Action - Category: International Medicine & Public Health Tags: Glob Health Action Source Type: research
The incidence of mouth and throat cancers caused by the human papilloma virus in men has now surpassed the incidence of HPV-related cervical cancers in women.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Head and Neck Cancer Human Papillomavirus (HPV) Sexually Transmitted Diseases Throat Smoking and Tobacco Men and Boys Vaccination and Immunization Infections Source Type: news
Publication date: Available online 16 October 2017 Source:Gynecologic Oncology Reports Author(s): Menon Sonia, Rossi Rodolfo, Stacy G. Harmon, Hillary Mabeya, Steven Callens Women living with HIV in Africa are at increased risk to be co-infected with Human Papilloma Virus (HPV), persistent high risk (HR) HPV infection and bacterial vaginosis (BV), which compounds HPV persistence, thereby increasing the risk for cervical dysplasia. New guidance from WHO in 2014 advocating for a “screen and treat” approach in resource poor settings is becoming a more widely recommended screening tool for cervical cancer preventi...
Source: Gynecologic Oncology Reports - Category: OBGYN Source Type: research
Authors: Poljak M, Šterbenc A, Lunar MM Abstract INTRODUCTION: In comparison to their HIV-negative counterparts, people living with HIV (PLWH) have a higher prevalence of human papillomavirus (HPV) infection in various anatomical sites coupled with increased HPV persistence, higher risk of HPV-related tumors, and faster disease progression. Areas covered: Gender-neutral prevention strategies for HPV-related cancers in PLWH discussed: ABC approach, HPV vaccination, antiretroviral treatment (ART), anal cancer screening, and smoking cessation. Gender specific strategies: cervical cancer screening reduces the in...
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Tags: Expert Rev Anti Infect Ther Source Type: research
Almost all cases of cervical cancer are caused by human papillomavirus (HPV). China accounts for about a third of the global burden of cervical cancer, with about 98 900 new cases of cervical cancer in China in 2015.1 After 10 years of the HPV vaccine being available in developed countries, HPV vaccines were finally approved in mainland China in 2016. On July 31, 2017, it was announced that HPV vaccines will gradually be made available in community health centres across 17 provinces.2
Source: LANCET - Category: General Medicine Authors: Tags: Correspondence Source Type: research
Follow me on Twitter @RobShmerling Did you know certain viruses can cause cancer? Two common examples include hepatitis C (which is linked with liver cancer) and human papilloma virus (HPV, which causes cervical cancer). The discovery of these virus-cancer connections is particularly important, because if a vaccine can prevent these viral infections it may also prevent cancer. And there is preliminary evidence that the HPV vaccine is making this happen. More on that in a moment. What is HPV? HPV is a group of viruses that may cause warts (papillomas) and a variety of cancers, including those involving the throat, rect...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Health Infectious diseases Prevention Sexual Conditions Vaccines Source Type: blogs
This article is protected by copyright. All rights reserved.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Research Article Source Type: research
Bravo Most infections by human papillomaviruses (HPVs) are `acute’, that is non-persistent. Yet, for HPVs, as for many other oncoviruses, there is a striking gap between our detailed understanding of chronic infections and our limited data on the early stages of infection. Here we argue that studying HPV acute infections is necessary and timely. Focusing on early interactions will help explain why certain infections are cleared while others become chronic or latent. From a molecular perspective, descriptions of immune effectors and pro-inflammatory pathways during the initial stages of infections have the potenti...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
In this study, a novel vaccine strategy was developed based on a rationally shuffled HPV16 E6/E7 fusion protein, the addition of Fms-like tyrosine kinase-3 ligand (Flt3L) or the N domain of calreticulin (NCRT), and the usage of a CpG adjuvant. Four recombinant proteins were constructed: m16E6E7 (mutant E6/E7 fusion protein), rm16E6E7 (rearranged mutant HPV16 E6/E7 fusion protein), Flt3L-RM16 (Flt3L fused to rm16E6E7), and NCRT-RM16 (NCRT fused to rm16E6E7). Our results suggest that Flt3L-RM16 was the most potent of these proteins in terms of inducing E6- and E7-specific CD8(+) T cell responses. Additionally, Flt3L-RM16 sig...
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
More News: African Health | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Education | Government | Infectious Diseases | Men | Middle East Health | Vaccines